|
Volumn 79, Issue 1-5, 2001, Pages 209-212
|
Faslodex (ICI 182, 780), a novel estrogen receptor downregulator - Future possibilities in breast cancer
|
Author keywords
Breast cancer; Estrogen antagonist; Faslodex; ICI 182, 780; Tamoxifen
|
Indexed keywords
ANASTROZOLE;
ESTROGEN RECEPTOR;
FULVESTRANT;
TAMOXIFEN;
BREAST CARCINOMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOTOXICITY;
DOSE RESPONSE;
DOWN REGULATION;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG MECHANISM;
ESTROGEN BLOOD LEVEL;
HUMAN;
POSTMENOPAUSE;
PROTEIN EXPRESSION;
REDUCTION;
TREATMENT FAILURE;
BREAST NEOPLASMS;
CLINICAL TRIALS;
DOWN-REGULATION;
ESTRADIOL;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
HUMANS;
NEOPLASMS, HORMONE-DEPENDENT;
RECEPTORS, ESTROGEN;
TAMOXIFEN;
|
EID: 0035718191
PISSN: 09600760
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-0760(01)00138-8 Document Type: Conference Paper |
Times cited : (65)
|
References (23)
|